In the first part of the study, the modified expression of these miRNAs in two classifications of muscular dystrophy was examined, the initial one retaining an intact expression of the dystrophin-linked glycoprotein complex (DAPC) (DMD, SGCA, and SGCG) and second category involving the compromised structural integrity of the DAPC (CAPN3, DYSF, healthy controls). The gene discussed is DMD; the disease is muscular dystrophy.